​

Zura Bio (ZURA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

ZURA Stock Forecast

Zura Bio (ZURA) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $15.00 and a low of $3.00. This represents a 143.90% increase from the last price of $3.69.

- $3 $6 $9 $12 $15 High: $15 Avg: $9 Low: $3 Last Closed Price: $3.69

ZURA Stock Rating

Zura Bio stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 1 Strong Buy (14.29%), 5 Buy (71.43%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 5 1 Strong Sell Sell Hold Buy Strong Buy

ZURA Price Target Upside V Benchmarks

TypeNameUpside
StockZura Bio143.90%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$9.00
Last Closing Price$3.69$3.69$3.69
Upside/Downside--143.90%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 25151--7
Sep, 25-51--6
Aug, 25151--7
Jul, 25151--7
Jun, 25151--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 03, 2025Mitchell KapoorH.C. Wainwright$3.00$1.09175.23%-18.70%
Nov 08, 2024Yatin SunejaGuggenheim$15.00$4.58227.51%306.50%
Sep 05, 2024Mitchell KapoorH.C. Wainwright$5.00$3.9526.58%35.50%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 03, 2025H.C. WainwrightBuyBuyhold
Mar 26, 2025OppenheimerOutperformOutperformhold
Nov 08, 2024GuggenheimBuyBuyhold
Nov 04, 2024Leerink PartnersOutperforminitialise
Sep 19, 2024Piper SandlerOverweightOverweighthold
Sep 05, 2024H.C. WainwrightNeutralinitialise
Jun 12, 2024Cantor FitzgeraldOverweightinitialise
May 03, 2024Piper SandlerOverweightinitialise
Apr 01, 2024OppenheimerOutperformOutperformhold
Oct 10, 2023Societe GeneraleBuyinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.09$-0.60----
Avg Forecast$-2.62$-0.67$-0.74$-0.91$-1.23$-1.46
High Forecast$-2.29$-0.59$-0.38$-0.57$-0.69$-1.46
Low Forecast$-2.81$-0.74$-1.32$-1.75$-1.93$-1.46
Surprise %-20.23%-10.45%----

Revenue Forecast

$5M $12M $19M $26M $33M $40M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast---$8.33M$37.50M$25.80M
High Forecast---$8.33M$37.50M$25.80M
Low Forecast---$8.33M$37.50M$25.80M
Surprise %------

Net Income Forecast

$-95M $-78M $-61M $-44M $-27M $-10M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-60.36M$-45.39M----
Avg Forecast$-84.34M$-22.03M$-28.07M$-38.35M$-43.31M$-48.19M
High Forecast$-75.86M$-19.66M$-12.55M$-18.85M$-22.81M$-48.19M
Low Forecast$-92.81M$-24.40M$-43.60M$-57.86M$-63.81M$-48.19M
Surprise %-28.43%106.03%----

ZURA Forecast FAQ

Is Zura Bio stock a buy?

Zura Bio stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 5 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Zura Bio is a favorable investment for most analysts.

What is Zura Bio's price target?

Zura Bio's price target, set by 7 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $3 at the low end to $15 at the high end, suggesting a potential 143.90% change from the previous closing price of $3.69.

How does Zura Bio stock forecast compare to its benchmarks?

Zura Bio's stock forecast shows a 143.90% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Zura Bio over the past three months?

  • October 2025: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 0% Strong Buy, 83.33% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.

What is Zura Bio’s EPS forecast?

Zura Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.74, marking a 23.33% increase from the reported $-0.6 in 2024. Estimates for the following years are $-0.91 in 2026, $-1.23 in 2027, and $-1.46 in 2028.

What is Zura Bio’s revenue forecast?

Zura Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $8.33M, followed by $37.5M for 2027, and $25.8M for 2028.

What is Zura Bio’s net income forecast?

Zura Bio's net income forecast for the fiscal year ending in December 2025 stands at $-28.075M, representing a -38.14% decrease from the reported $-45.386M in 2024. Projections indicate $-38.354M in 2026, $-43.314M in 2027, and $-48.191M in 2028.